In focus
Latest feed
The Million-Dollar Question: Unpacking the FDA Chief's Gene Therapy Warning
The End of an Era: Doug Ingram Prepares to Retire from Sarepta, Elizabeth Barrett Named Successor
A Legal Storm Brews: Sarepta's Groundbreaking Muscular Dystrophy Therapy Faces Renewed Patent Challenge
A Vital Step Forward: Sarepta's Duchenne Drug Secures Key Testing Clearance
